Day: September 2, 2024

Zacks Small Cap Research – VNRX: Nu.Q Vet Test is now available in 17 countries. Cost cutting continues in a plan to be cash flow neutral in 2025. Management focused on signing licensing deals for Capture-PCR (human cancer detection method) and Nu.Q NET for sepsis. $7.0 million financing completed. – Technologist

By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT SIGNIFICANT OPERATIONAL UPDATES Management is implementing a significant cost cutting program with the goal...

How To Money on SEO – Technologist

It’s no surprise that money matters remain the most pressing challenge for small businesses. Naturally, such companies look to save money on SEO (search engine...
x